3M Health Care

3M previously announced it would retain a 19.99 percent interest in whomever purchased the remaining 80.01 of their Health Care division.

Mr. Rohit Kashyap a former KCI president, recently left MiMedx, to return to a key 3M Health Care competitor, Smith & Nephew.

Smith & Nephew’s debt is slightly over $2 billion, while 3M holds over $12, with significant legal challenges at home and abroad.

Mr. Kashyap’s 20+ year familiarity with the offerings of the former KCI (now 3M), coupled with his exceptional performance from his Smith & Nephew days, would make him a top tier candidate to run the combined health care organization. There are synergies in terms of complimentary product offerings, patents, etc.

For hospitals previously forced to choose 3M or Smith & Nephew, having all products available under one umbrella would present potential cost savings; eliminating funding two separate firms.

If two companies wanted to hit the ground running with only a mild learning curve, Mr. Kashyap may be the best bet to lead the new venture.

Comment! It's anonymous!

6 replies (most recent on top)

I agree. KCI was profitable prior to the 3M acquisition.

Wound care only would not make sense and if Smith & Nephew holds 80.01 percent, I see them embracing all 3M health care offerings.

The key is to get out from underneath 3M (AKA GE) leadership / control.

Re: It is time to shelf the “3M Way”, and to put those in charge that actually have a proven track record of success. How many losing seasons are needed before folks realize the 3M approach is fundamentally and fatally flawed?

You're preaching to the choir, bud! Although what's going on right now is definitely not the "3M Way". More like "GE Way"? Regardless, most everyone with any common sense agrees the "way" is failing miserably. If folks get put leaders in charge with proven track records of success, it would have been done long ago.

Facts are stubborn things.

Not one year, not one, since 3M purchased KCI has the health care budget been met.

Profits continue to slide despite layoffs, budget cuts, and a new sales approach every six months.

It is time to shelf the “3M Way”, and to put those in charge that actually have a proven track record of success.

How many losing seasons are needed before folks realize the 3M approach is fundamentally and fatally flawed?

Unfortunately this would spell death to any products that are NOT wound care. I can see those being sold asap to anyone and Spinco would just be wound care.

Interesting. What prompted this?

Is this post a proposition by RK?

Thread regarding 3M layoffs

3M Health Care

6 replies (most recent on top)

Post a reply